Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05515341 · ClinicalTrials.gov registry record
A DirEct to PatieNt Study in Chronic Pain
A clinical trial of Chronic Pain, sponsored by Boston Scientific Corporation.
- Recruiting
- Registry status
- 50,000
- Enrollment target
- 1
- Study location
NCT05515341: Recruiting study of Chronic Pain, sponsored by Boston Scientific Corporation.
NCT05515341 is a study of Chronic Pain that is actively recruiting participants, run by Boston Scientific Corporation. The registered enrollment target is 50,000 participants, above the 606-participant average among 301 other Chronic Pain trials with a reported enrollment target (8151% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05515341, a study of Chronic Pain, is actively recruiting participants, sponsored by Boston Scientific Corporation.
- RECRUITING
- Registry status
- 50,000 participants
- Enrollment target
- 1
- Study location
Study Summary
To compile real-world, direct from patient clinical outcomes and objective metrics in patients who have received or plan to receive a commercially approved interventional medical device therapy/procedure for chronic pain in routine clinical practice.
Primary Outcome
Percentage of subjects with a 50 percent or greater reduction in targeted pain intensity, based on self-reported percent pain relief
Conditions Studied
Interventions
- DEVICE Commercially Approved Interventional Medical Device/Therapy for Chronic Pain
Study Locations (1)
California
- Boston Scientific Neuromodulation - Valencia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50,000 participants |
| Start Date | 2023-01-10 |
| Est. Completion | 2029-12 |
What NCT05515341 shows while recruiting
NCT05515341 is an observational study that tracks outcomes without assigning an intervention. Its 50,000 participants enrollment target places it among the larger protocols in the corpus, above the 606-participant average among 301 other Chronic Pain trials with a reported enrollment target (8151% higher).
The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 1 intervention - of which Commercially Approved Interventional Medical Device/Therapy for Chronic Pain is the first listed.
NCT05515341 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05515341 about?
NCT05515341 is a clinical study titled "A DirEct to PatieNt Study in Chronic Pain". To compile real-world, direct from patient clinical outcomes and objective metrics in patients who have received or plan to receive a commercially approved interventional medical device therapy/procedure for chronic pain in routine clinical practice.
What is the current status of trial NCT05515341?
This trial is currently recruiting. The enrollment target is 50,000 participants. The study started on 2023-01-10. Estimated completion is 2029-12.
What conditions does trial NCT05515341 study?
This clinical trial studies the following conditions: Chronic Pain.
What interventions are being tested in trial NCT05515341?
The interventions under investigation include: Commercially Approved Interventional Medical Device/Therapy for Chronic Pain (DEVICE).
Who is sponsoring clinical trial NCT05515341?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05515341 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05515341's enrollment target sits among peer trials
50,000 2nd of 301 higher than 299 of 301 other Chronic Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating the Acceptability, Feasibility and Usability of Various Conversational Data Collection Software
RECRUITING · NA
-
Local Cerebral Oxygenation in Chronic Pain Patients Utilizing Spinal Cord Stimulation
RECRUITING · NA
-
Group Medical Visits and Chiropractic Care for Older Adults With Chronic Spine Pain
RECRUITING · NA
-
Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma
RECRUITING · NA
-
Group-based Integrative Pain Management in Primary Care Safety Net Clinics
RECRUITING · NA
-
Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00500123 · 50,000 participants
The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT) Study
- NCT01885299 · 50,000 participants
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
- NCT03452774 · 50,000 participants
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- NCT04629586 · 50,000 participants
The T1D Exchange Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI